Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

GMED 25.27 -0.30 (-1.17%)
price chart
Company Shares of Globus Medical, Inc. Drops by -2.26%
Globus Medical, Inc. (NYSE:GMED) has lost 2.26% during the past week and dropped 1.8% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 1.09%.
Value Stock Watch: Globus Medical, Inc. (NYSE:GMED)
Globus Medical, Inc. (NYSE:GMED) has been identified as a value stock according to Zacks Research. Value stock investors typically look for equities that are trading at a lower price relative to the company's fundamentals, such as earnings, sales and ...
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by ...
LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED) concerning the Company's and its officers' ...
Globus Medical, Inc. Engages Grant Thornton LLP as Independent Auditor
AUDUBON, Pa., Jun 09, 2015 (BUSINESS WIRE) -- Globus Medical, Inc. GMED, -0.92% a leading musculoskeletal implant manufacturer, today announced that the Audit Committee of its Board of Directors has engaged Grant Thornton LLP as its independent ...
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Globus Medical, Inc. (NYSE:GMED) Analyst Rating Update
As many as 11 brokerage firms have rated Globus Medical Inc (NYSE:GMED) at 1. Research Analysts at Zacks have ranked the company at 2, suggesting the traders with a rating of buy for the short term.
Harwood Feffer LLP Announces Investigation of Globus Medical, Inc.
NEW YORK, April 27, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED), concerning whether the board has breached ...
Stock Rating Update on Globus Medical, Inc. (NYSE:GMED)
Globus Medical, Inc. (NYSE:GMED) has been issued a 1 rating by the sell-side brokerage firms covering the stock. Basing the rating on a simplified scale where 1 represents a Buy and 5 represents a Sell, this is the average rating based on the 8 firms ...
Is there Value for Investors: Globus Medical, Inc. (NYSE:GMED)
We look at Globus Medical, Inc. (NYSE:GMED) a company in the Healthcare industry which traders have been highly interested in of late, to assess if it provides value for investors considering buying or selling it.
Globus Medical, Inc. Investors Encouraged to Contact Securities Law Firm about ...
NEW YORK, April 30, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Globus Medical, Inc. shareholders GMED, -0.82% Concerned GMED investors who purchased prior to April 22, 2015 are encouraged to ...